黄风杰，女，1977.1出生，微生物与生化药学博士，中国药科大学生命科学与技术学院副教授。现主要从事微生物和生物制药的教学和科研工作，主持并参与多项课题攻关任务，拥有多项发明专利，在专业刊物了发表了数十篇学术论文。

人物简介

科研项目

论文著述

专利成果

人物简介

女，1977.1出生，微生物与生化药学博士，副教授.现主要从事微生物和生物制药的教学和科研工作，研究方向，天然产物的分离纯化，药物治疗学的机理研究，与糖尿病有关的药理学试验方法和代谢调控机制基本研究工作，对以疾病动物模型为实验对象的基础药物治疗学研究有着丰富的实践经验。

科研项目

1. 鲨肝S－8300防治糖尿病作用机制及其基因克隆表达，国家自然科学基金资助，批准号30701036

2. 鲨鱼肝低分子多肽抗糖尿病活性物质研究，编号211032，中国药科大学引进人才启动基金资助

目前主要参与科研项目

1. Ⅰ类抗肝炎新药鲨肝刺激物质HSS的临床前研究，国家海洋863计划资助，批准号. 2005AA624090

2. 三明治式抗肿瘤基因靶向载体技术的研究，国家自然科学基金资助，批准号30672548

3. 重组水蛭素III的新用途与新剂型研究，教育部博士学科点专项基金，批准号20040316005

4. 鲨肝HSS的一级结构、基因克隆与防治肝炎的作用机制，国家自然科学基金资助，批准号. 30171103

论文著述

1. Qian Sheng Pan, Zhi Ping Fang andFeng Jie Huang. Identification, localization and morphology of APUD cells in gastroenteropancreatic system of stomach-containing teleosts. World Journal of Gastroenterology, 2000; 6(6): 842-847

2.FANG Zhi-ping, PAN Qian-sheng, HUANG Feng-jie, LUO Li-ting and HEJie STUDIES ON HISTOLOGY AND SCANNING ELECTRON MICROSCOPE OF DIGESTIVE TRACT OF CHINESE MITTEN-HANDED CRAB (ERIOCHEIRSINENSIS). ACTA HYDROBIOLOGICA SINICA，2002; 26(2): 136-141

2. Lü Zheng-Bing, HUANG Feng-Jie, LI Qian, YE Bo-Ping, WU Wu-Tong. Protective Effects of Shark Stimulator Substance (sHSS) against Acute Hepatic Injury Induced by APP in Mice. ACTA BIOCHIMICA et BIOPHYSICA SINICA, 2003; 35(11): 1051

3.HUANG Feng-jie,LI Qian, Lv Zheng-bing,etal. Protective effect of peptide S-8300 from shark liver on acute liver Injury in mice.Chinese Journal of Marine Medicines，2004：23（1）：17-20

4. HUANG Feng-jie, WU Wu-tong. Study on Immunoloregulation Effect of Peptide S-8300 from Shark Liver. Chinese Journal of Natural Medicines，2005，3（2）：121－123

5．ZHANG Liang, WEI Li-Jun, HUANG Feng-Jie, WU Wu-Tong. Effect of a Proposed Lyoprotectant on the Cytotoxin ACTX-6 Purified from Snake Venom. Journal of China Pharmaceutical University, 2005(2)：183

6.Fengjie Huang, Wutong, Wu. Antidiabetic effect of a new peptide from squalus mitsukurii liver (S-8300) in Alloxan-induced diabetes. Clinical and Experimental Pharmacology and Physiology, 2005, 32: 521-525.ISSN：0305-1870

7. ZHANG Liang, WEI Li-Jun，HUANG Feng-Jie, WU Wu-Tong. Effect of a Proposed Lyoprotectant on the Cytotoxin ACTX-6 Purified from Snake Venom. Journal of China Pharmaceutical University, 2005(2)：183

8.Fengjie Huang, Wutong, Wu. Antidiabetic effect of a new peptide from squalus mitsukurii liver (S-8300) in Streptozotocin-induced diabetes. Journal of Pharmacy and Pharmacology, 2005,57: 1575-1580. ISSN: 0022-3573

9. Feng-Jie Huang，Zheng-Bing Lv， Qian Li， Li-Jun Wei，Liang Zhang, Wu-Tong Wu. Study on Hepatoprotective Effect of Peptide S-8300 from Shark Liver. World Journal of Gastroenterology, 2005;11（12）：1809-1812; ISSN 1007-9327

10．HUANG Feng-Jie, WU Wu-Tong. Development and Market of Chinese Biopharmaceutical Industry. Progress in Pharmaceutical Science. 2006，30(4):185-191

11．HUANG Feng-Jie, HE Shu-Ying,WU Wu-Tong. Discussion on the Necessity of the Name Change from Microbiology&Biochemical Pharmacy to Biophamaceutical Sciences.Pharmaceutical Education，2006，22（5）：14-18

12. WU Wu-Tong, HUANG Feng-Jie. Advances in biopharmaceutical technology in china. Chapter 2and Chapter 20, September, 2006, Society for industrial microbiology and BioPlan Associates, Inc.

13．SONG Li-Na,HUANG Xiao-Dong,LEI Hong,LI Qian,OU Yu, HUANG Feng-Jie,WU Wu-Tong. Hepatocyte Proliferation and Damaged B-cell Protective Effect of a New Hepatocyte Stimulate Peptide(sHSP）from Shark Liver.Chin J Nat Med,2007,15 (14):306-311

14. HUANG Feng-Jie, QIAN Jing, WU Wu-Tong. Study on Anti-apoptosis of S-8300 in alloxan-diabetes. CHINESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007,9(12):993-997

15 HUANG Feng-Jie, WU Wu-Tong. Study on the effect of anti-diabetes and cell protection of a new peptide S-8300. CHINESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS，2007,11(12):1283-1287

16. HUANG Feng-jie,WU Wu-tong. Study on hypoglycemic mechanism of S-8300 inalloxan-diabete. CHINESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS，2008，13（5）：494-498

17. LV Li-li, HUANG Feng-jie, WU Wu-tong. The Effect of Secretory Recombinant Shark Hepatic Active Proteinon the Hepatic Glucokinase in Vitro. Pharmaceutical Biotechnology，2008，15（6）：439-443（Correspondence）

18.JI Jing-xian, QIAN Jing, HUANG Feng-jie, WU Wu-tong, GAO Xiang-dong. Study on the active principles and pharmacological actions of hairy antler. Chinese Journal of Biochemical Pharmaceutic, 2009，30（2）：141-143

19. Fengjie Huang and Wutong Wu. Study on the antidiabetic mechanism of a shark liver peptide,S-8300, in alloxan-induced diabetes. Journal of Pharmacy and Pharmacology，2009; 61: 789–794

20. Huang F, Wu W. Purification and characterization of a new peptide (S-8300) from shark liver. J Food Biochem (in press).

专利成果

吴梧桐，黄凤杰. 一种新的鲨肝活性肽、其制备方法及其治疗用途，中国发明专利. 专利号: ZL200510037679.2

吴梧桐，黄凤杰，钱璟，吉静娴. 一种源自鹿花盘的多肽、其制法及其防治糖尿病的用途.申请号: 200810234865.9，公开日：2009.04.08